NCI Community Oncology Research Program - Kansas City (NCORP-KC)
NCI Community Oncology Research Program - Kansas City (NCORP-KC)




GU Clinical Trials

Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.

 

If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.



Prostate

SWOG S1216 - "A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK‐700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer"

CANCER TYPE: Prostate
RESEARCH BASE: SWOG S1216
NCT NUMBER: 01809691
Protocol Summary: VIEW SUMMARY
Consent Form: VIEW CONSENT FORM
BRIEF DESCRIPTION

PROSTATE, Mets (newly dxd, no brain mets), hormone-sensitive, PSA >=2ng/mL; Androgen Deprivation + TAK-700 vs Androgen Deprivation + Bicalutamide






Urinary Tract

SWOG S1314 - "A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer"

CANCER TYPE: Urinary Tract
RESEARCH BASE: SWOG
NCT NUMBER: NCT02177695
Protocol Summary: VIEW SUMMARY
Consent Form: VIEW CONSENT FORM
BRIEF DESCRIPTION

Stage II or III, urothelial bladder ca, neoadj. Gemcitabine/Cisplatin vs Methotrexate/Vinblastine/Doxorubicin/Cisplatin









  © 2013-2017 All Rights Reserved. Privacy Policy | Terms & Conditions
NCI Community Oncology Research Program - Kansas City (NCORP-KC)
Questions? Call: +1-913-948-5588 | Contact Us
4121 W. 83rd St., Suite 259 Prairie Village, KS 66208 USA